Home
Rezolute, Inc.

Rezolute, Inc. Market Share Analysis for May 2026

Rezolute is a late-stage rare disease company focused on developing ersodetug, a potential treatment for hypoglycemia caused by congenital and tumor hyperinsulinism (HI).

Industry: N/A

Domainrezolutebio.com

Year Founded2010

Employees51 - 200

Annual Revenue$10M - $15M

Rezolute, Inc.

Rezolute, Inc. (including company regionals)

rezolutebio.com

See more website traffic and engagement information

Rezolute, Inc. Revenue up to May 2026 is 10M - 15M

revenue generated by Rezolute, Inc. top domains

Rezolute, Inc. top domains revenue over 3 years

Revenue for Rezolute, Inc. top domains

rezolutebio.com10M - 15M

See more with Sales Intelligence

Total visits to Rezolute, Inc.'s top domains

Understand Rezolute, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

rezolutebio.com5.9K

See more with Sales Intelligence

Avg. visit duration in Rezolute, Inc.'s top domains

Analyze Rezolute, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

rezolutebio.com00:00:46

See more with Sales Intelligence

Avg. pageviews on Rezolute, Inc.'s top domains

See how Rezolute, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

rezolutebio.com1.80

See more with Sales Intelligence

Rezolute, Inc. top competitors by domain

Top similar sites in May 2026, ranked by their affinity

clinicaltrials.govCompany NameClinicalTrials.govEmployees201 - 500HQUnited States, North Carolina, DurhamAnnual revenue$15M - $25MTotal visits3.3MHealth > Health - Other

Top technologies used by Rezolute, Inc.

These are the website technologies, by industry, used by Rezolute, Inc. top domains

Payment & Currencies (10)

Cart Functionality

Widget (7)

Twemoji

eCommerce (4)

OpenCart

Cryptocurrency (3)

Bitcoin Acceptance

More Technologies

11

See all

News & Signals from Rezolute, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsRezolute attended event Pediatric Endocrine Society (PES) Annual Meeting on Apr 30th '26.REDWOOD CITY, Calif., April 21, 2026 (GLOBE NEWSWIRE) - Rezolute, Inc. (Nasdaq: RZLT) ("Rezolute" or the "Company"), a late-stage rare disease company focused on treating hypoglycemia caused by all forms of hyperinsulinism (HI), today announced that results from the Phase 3 sunRIZE study of ersodetug in congenital HI were accepted for an oral presentation at the Pediatric Endocrine Society (PES) Annual Meeting being held April 30-May 3, 2026, in San Francisco, CA.

NewsRezolute will attend event Citizens Life Sciences Conference on Mar 10th '26.REDWOOD CITY, Calif., March 04, 2026 (GLOBE NEWSWIRE) - Rezolute, Inc. (Nasdaq: RZLT) ("Rezolute" or the "Company"), a late-stage rare disease company focused on treating hypoglycemia caused by all forms of hyperinsulinism (HI), today announced that management will participate in the Citizens Life Sciences Conference, taking place March 10-11, 2026, in Miami, FL.

NewsRezolute attends event Guggenheim Emerging Outlook: Biotech Summit 2026.Rezolute to participate in the Guggenheim Emerging Outlook: Biotech Summit 2026.